News

CardioKinetix Inc. announced it has completed a $50 million financing led by Edwards Lifesciences Corp. with participation from other existing investors. This financing provides CardioKinetix with...

Stem cell therapies, heart failure, bone marrow cells, clinical trial

CardioCell LLC announced the treatment of its first patient in the University of Pennsylvania’s Phase IIa clinical trial for chronic heart failure (HF) of non-ischemic cardiomyopathy. 

COR Medical Technologies (COR) introduces CORcare, a comprehensive instant outcome support system for rapid and accurate diagnosis, treatment, and follow-up management of patients with acute and...

BioCardia Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s application to begin a Phase III clinical trial of its bone marrow-derived CardiAMP...

BioCardia Helix Catheter

BioCardia Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s application to begin a Phase III clinical trial of its bone marrow-derived CardiAMP Therapy...

Blipcare, wireless weight scale, heart failure, patient engagement

According to a statement in Health Data Management, Ochsner Health System in New Orleans, developed a program utilizing a Carematix Blipcare wireless weight scale for remote patient...

syncardia, artificial heart

A 19-year-old woman was successfully implanted with the SynCardia temporary Total Artificial Heart and bridged to a donor heart transplant after cardiac surgeons used 3-D virtual...

The American College of Cardiology (ACC), which has been developing clinical practice guidelines in partnership with the American Heart Association (AHA) for more than three decades, has launched...

The American College of Cardiology announced 35 selected hospitals that are pioneering a team approach to keep patients healthy and at home following admission for heart attack or heart failure....

Sorin Group announced today a $20 million minority investment in Respicardia, a developer of implantable therapies to improve Respiratory Rhythm Management. Under the terms of the transaction,...

The Cardiovascular Cell Therapy Research Network (CCTRN) has selected Cytori Therapeutics Inc. to supply adipose-derived regenerative cells (ADRC) for a clinical trial aimed at...

Sunshine Heart Inc. today announced the results of its feasibility study entitled “Ambulatory Extra-Aortic Counterpulsation in Patients with Moderate to Severe Chronic Heart Failure,”...

October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its investigational heart failure medicine, LCZ696, was superior to the ACE-...

Healthline today launched its HealthData Engine to harness the power of structured and unstructured data to improve outcomes and reduce costs. The new big-data analytics platform...

In partnership with Intel-GE Care Innovations, Cigna-HealthSpring is expanding its population health program that utilizes interactive tablets – the Intel-GE Care Innovations Guide – and...

Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating and preventing heart failure...

LoneStar Heart Inc.Algisyl-LVR Hydrogel Implant Heart Failure Treatment CE Mark

LoneStar Heart Inc. announced that it received the CE mark (Conformite Europeene) for its Algisyl-LVR hydrogel implant, the company's lead product for the treatment of advanced heart failure (HF...

CardiacAssist Inc. announced that the first Protek Duo veno-venous extracorporeal life support (VV ECLS) kit was utilized Sept. 24, at Memorial Hermann Hospital in Houston.

October 8, 2014 — New updates to the Society for Cardiovascular Angiography and Interventions (SCAI) appropriate use criteria (AUC) calculator tool will help healthcare providers in making...

Clinical trial results by Recover Right revealed a survival rate of 73 percent in the total patient population. Recover Right was an FDA-approved, prospective, multicenter, single arm study...